Pharmacogenomics of Bipolar Disorder

Abstract excerpt

Bipolar disorder (BD) is a lifelong severe psychiatric condition with high morbidity, disability and excess mortality. The longitudinal clinical trajectory of BD is significantly modified by pharmacological treatment(s), both in acute and in long-term stages. However, a large proportion of BD patients have inadequate response to pharmacological treatments. Pharmacogenomic research may lead to the identification...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bipolar Disorder and Treatment
• Share to Genetics and Neurodevelopmental Disorders
• Share to Phosphodiesterase function and regulation